Acadian Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Hold |
917,846
| – | – | 0.01% | 692 |
|
|
2025
Q1 | $2.74M | Sell |
917,846
-15,079
| -2% | -$45.1K | 0.01% | 678 |
|
|
2024
Q4 | $3.12M | Hold |
932,925
| – | – | 0.01% | 657 |
|
|
2024
Q3 | $3.12M | Sell |
932,925
-1,580
| -0.2% | -$5.29K | 0.01% | 620 |
|
|
2024
Q2 | $3.09M | Sell |
934,505
-27,953
| -3% | -$92.5K | 0.01% | 639 |
|
|
2024
Q1 | $3.89M | Hold |
962,458
| – | – | 0.01% | 530 |
|
|
2023
Q4 | $2.93M | Sell |
962,458
-25,458
| -3% | -$77.6K | 0.01% | 581 |
|
|
2023
Q3 | $2.96M | Sell |
987,916
-8,359
| -0.8% | -$25.1K | 0.01% | 578 |
|
|
2023
Q2 | $3.72M | Sell |
996,275
-114,440
| -10% | -$428K | 0.02% | 529 |
|
|
2023
Q1 | $3.72M | Buy |
1,110,715
+242,465
| +28% | +$812K | 0.02% | 536 |
|
|
2022
Q4 | $4.17M | Buy |
868,250
+42,487
| +5% | +$204K | 0.02% | 495 |
|
|
2022
Q3 | $4.7M | Buy |
825,763
+111,341
| +16% | +$633K | 0.03% | 410 |
|
|
2022
Q2 | $5.07M | Sell |
714,422
-138,154
| -16% | -$981K | 0.03% | 411 |
|
|
2022
Q1 | $6.15M | Buy |
852,576
+580,315
| +213% | +$4.19M | 0.03% | 420 |
|
|
2021
Q4 | $2.43M | Buy |
272,261
+241,916
| +797% | +$2.16M | 0.01% | 610 |
|
|
2021
Q3 | $1.06M | Sell |
30,345
-3,369
| -10% | -$118K | ﹤0.01% | 833 |
|
|
2021
Q2 | $724K | Buy |
+33,714
| New | +$724K | ﹤0.01% | 1026 |
|